CQDM welcomes Zymeworks as a new member of CQDM’s biopharmaceutical consortium

News & Events

Montreal, February 27, 2020 – CQDM is pleased to welcome Zymeworks Inc. as a new member of its biopharmaceutical research consortium established to identify and invest in highly innovative biopharmaceutical research projects in Quebec and Canada with the ultimate goal of enabling the development of better treatments for patients. As a CQDM member, Zymeworks will benefit from the consortium’s ability … Read More

2nd Annual Gordon Shore Prize – Postdoctoral Internships in the Biopharmaceutical Industry

News & Events

Presented by CQDM, Diazon Pharmaceuticals and Mitacs, the Gordon Shore Prize is awarded to new graduates whose doctoral thesis demonstrated their research excellence in the life science field. A 6-month postdoctoral internship of $24,000 will be offered to each of the awardees by the participating Quebec-based companies: Feldan Therapeutics, Kisoji Biotechnology, Ovensa Innovations and Repare Therapeutics. To be eligible, candidates … Read More

We are recruiting! Interested in a Controller – finance & administration position? Apply now!

Job offers, News & Events

Controller – finance & administration ABOUT CQDM  Since its creation, CQDM has raised nearly $100 million to fund the development of approximately 80 outstanding technologies addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. … Read More

Project funded through CQDM will explore potential of Fusion Genomics’ ONETest™ to improve diagnosis of respiratory tract infections

News & Events

We’re delighted to announce that Fusion Genomics has been awarded $1 million to conduct a prospective clinical study evaluating its product: ONETest™. The project will be funded through our Quantum Leap program with support from Merck and will explore the improvement for diagnosis of respiratory tract infections. Fusion Genomics ONETest™ is a highly sensitive, cost-effective next-generating sequencing-based assay capable of … Read More